NCT04346901View on ClinicalTrials.gov

Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

January 27, 2020

Study Completion Date

February 15, 2020

Conditions
MelasmaHyperthyroidism
Interventions
DRUG

Thiamazol

All new hyperthyroid with melasma patients were recruited and their mMASI were calculated All subjects were given thiamazole by Internist based on their clinical hyperthyroidism After 3 months of taking hyperthyroid drugs (thiamazole), mMASI were recalculated and compared

Trial Locations (1)

10430

dr. Cipto Mangunkusumo Hospital, Jakarta

All Listed Sponsors
lead

Dr.dr.Irma Bernadette, SpKK (K)

OTHER

NCT04346901 - Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma | Biotech Hunter | Biotech Hunter